Cargando…
Treatment of Rare Mutations in Patients with Lung Cancer
Lung cancer is a worldwide prevalent malignancy. This disease has a low survival rate due to diagnosis at a late stage challenged by the involvement of metastatic sites. Non-small-cell lung cancer (NSCLC) is presented in 85% of cases. The last decade has experienced substantial advancements in scien...
Autores principales: | Taha, Tarek, Khoury, Rasha, Brenner, Ronen, Nasrallah, Haitam, Shofaniyeh, Irena, Yousef, Samih, Agbarya, Abed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151457/ https://www.ncbi.nlm.nih.gov/pubmed/34064757 http://dx.doi.org/10.3390/biomedicines9050534 |
Ejemplares similares
-
Efficacy of the mRNA-Based BNT162b2 COVID-19 Vaccine in Patients with Solid Malignancies Treated with Anti-Neoplastic Drugs
por: Agbarya, Abed, et al.
Publicado: (2021) -
Hormone dependent metastatic salivary gland carcinoma: a case report
por: Agbarya, Abed, et al.
Publicado: (2014) -
Getting out of a wheelchair: an uncommon insertion mutation in exon 19 of EGFR responsive to erlotinib
por: Agbarya, Abed, et al.
Publicado: (2014) -
Adjuvant Treatment with Tyrosine Kinase Inhibitors in Epidermal Growth Factor Receptor Mutated Non-Small-Cell Lung Carcinoma Patients, Past, Present and Future
por: Shalata, Walid, et al.
Publicado: (2021) -
Response Rate of the Third and Fourth Doses of the BNT162b2 Vaccine Administered to Cancer Patients Undergoing Active Anti-Neoplastic Treatments
por: Agbarya, Abed, et al.
Publicado: (2023)